Paroxysmal Supraventricular Tachycardia in the General Population
نویسندگان
چکیده
منابع مشابه
Malignant Paroxysmal Supraventricular Tachycardia
A 63 year old male had a sudden episode of cardiac arrest during travel. He was resuscitated and cardioverted successfully with a semi-automatic defibrillator. The first ECG showed atrial fibrillation with inferior Q waves and he spontaneously reverted to sinus rhythm over the next few hours. The patient had been asymptomatic up to the episode of cardiac arrest and referred no prior history of ...
متن کاملInduction of Paroxysmal Supraventricular Tachycardia
mg, mean ± SD) of disopyramide for three to five doses over 24 hours and were then restudied. All patients had inducible, sustained PSVT during the control study. After disopyramide, PSVT was noninducible in eight patients (50%), including six of nine with atrioventricular nodal reentrance and two of seven with atrioventricular reentrance; inducible but nonsustained in two (12.5%) (both with at...
متن کاملCircadian variation of paroxysmal supraventricular tachycardia.
BACKGROUND Various clinical manifestations of cardiovascular diseases have a pattern of circadian variation. In this study, we investigated whether the onset and duration of paroxysmal supraventricular tachycardia (PSVT) has a circadian variation. METHODS AND RESULTS In our analysis, we included 105 patients with 498 PSVT episodes. In this study, the onset of PSVT did not have a uniform distr...
متن کاملCatheter ablation of paroxysmal supraventricular tachycardia.
Radiofrequency (RF) catheter ablation became first-line therapy for supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome1–5 and atrioventricular (AV) nodal reentrant tachycardia (AVNRT)6–11 in the early 1990s. High ablation success ( 90%) and low complication rates ( 5%) were found by numerous investigators.1–11 This article describes these ablation techniques with a foc...
متن کاملFlecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
Oral flecainide acetate was administered to 34 patients with documented symptomatic paroxysmal supraventricular tachycardia (PSVT) with a double-blind, placebo-controlled, 8-week crossover trial design. PSVT was defined as a regular tachycardia of at least 120 beats/min without evidence of atrioventricular dissociation. The study required considerable patient cooperation. Patients first entered...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 1998
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(97)00422-1